Bascom Palmer Eye Institute, University of Miami, Miami, Florida.
Bascom Palmer Eye Institute, University of Miami, Miami, Florida.
Ophthalmol Retina. 2022 Nov;6(11):992-1000. doi: 10.1016/j.oret.2022.05.023. Epub 2022 May 30.
To evaluate the clinical features, operative techniques, and surgical outcomes of patients who underwent surgery for acute retinal necrosis (ARN)-related retinal detachment (RD).
Retrospective, longitudinal, consecutive case series.
Patients with polymerase chain reaction-positive ARN presenting from 2011 to 2021 who underwent vitreoretinal surgery for ARN-related RD at our institution.
Univariate, multivariate, and survival analyses were used to determine predictors of anatomic and functional outcomes.
Single-surgery anatomic success rate, recurrent RD, and visual acuity (VA) at 1 year.
Thirty-four eyes of 34 patients (32.4% women, mean age, 45.1 ± 20.4 years) were included for analysis with a median follow-up of 2.5 years (interquartile range [IQR], 0.8-5.5 years). Presenting VA was 1.1 ± 0.8 logarithm of the minimum angle of resolution (LogMAR) (Snellen ∼20/250). The median time from presentation to RD surgery was 1.7 months (IQR, 0.8-4.1 months), and the mean preoperative VA was 1.6 ± 0.8 LogMAR (Snellen ∼20/800). Small-gauge pars plana vitrectomy (PPV) with or without a scleral buckle (SB) was performed for all eyes with an overall single-surgery success rate of 63.6%, with no statistically significant differences in visual/anatomic outcomes between PPV and PPV/SB cases. Silicone oil was used for tamponade in 33 (97.1%) cases and was removed in 10 (30.3%) with good anatomic and final functional outcomes (Snellen ∼20/80). Independent predictors of recurrent RD included the female sex (hazard ratio, 8.38; 95% confidence interval, 2.03-34.68; P < 0.01) and zone 1 retinitis involvement at presentation (hazard ratio, 10.95; 95% confidence interval, 2.12-56.48; P < 0.01). The mean VA at 1 year (VA) and at the final follow-up both had a Snellen equivalent of 20/640 (P > 0.05 for both compared with preoperative VA, respectively). Eyes that achieved single-surgery success had VA of 20/200 versus hand movements in those with single-surgery failure (P < 0.01). On multivariate linear regression, younger age (P = 0.04) and better presenting VA (P < 0.01) were both associated with better VA.
Moderate single-surgery anatomic success can be achieved with modern vitreoretinal surgical techniques for ARN-related RD, although visual outcomes remain poor. Further studies investigating interventions for increasing single-surgery success rates, for the inflammatory complications of ARN, and for preventing ARN-related RD are needed.
评估因急性视网膜坏死(ARN)相关视网膜脱离(RD)而行手术治疗的患者的临床特征、手术技术和手术结果。
回顾性、纵向、连续病例系列。
2011 年至 2021 年间聚合酶链反应(PCR)阳性 ARN 患者,在我院行玻璃体视网膜手术治疗 ARN 相关 RD。
采用单变量、多变量和生存分析来确定解剖和功能结果的预测因素。
单次手术解剖成功率、复发性 RD 和 1 年时的视力(VA)。
共纳入 34 只眼(32.4%为女性,平均年龄 45.1 ± 20.4 岁)进行分析,中位随访时间为 2.5 年(四分位距 [IQR],0.8-5.5 年)。就诊时 VA 为 1.1±0.8 对数最小角分辨率(LogMAR)(Snellen 视力约为 20/250)。从就诊到 RD 手术的中位时间为 1.7 个月(IQR,0.8-4.1 个月),术前平均 VA 为 1.6±0.8 LogMAR(Snellen 视力约为 20/800)。所有患者均行小切口经睫状体平坦部玻璃体切除术(PPV)联合或不联合巩膜扣带术(SB),单次手术总成功率为 63.6%,PPV 与 PPV/SB 病例之间的视力/解剖结果无统计学差异。33 例(97.1%)眼使用硅油作为眼内填充物,10 例(30.3%)眼硅油取出,最终解剖和功能结果良好(Snellen 视力约为 20/80)。复发性 RD 的独立预测因素包括女性(风险比,8.38;95%置信区间,2.03-34.68;P<0.01)和初诊时累及 1 区视网膜炎(风险比,10.95;95%置信区间,2.12-56.48;P<0.01)。1 年时(VA)和最终随访时的平均 VA 均为 Snellen 视力 20/640(与术前 VA 相比,两者均 P>0.05)。单次手术成功的眼 VA 为 20/200,而单次手术失败的眼 VA 为手动(P<0.01)。多变量线性回归分析显示,年龄较小(P=0.04)和初诊时 VA 较好(P<0.01)与 VA 较好相关。
现代玻璃体视网膜手术技术可实现中等程度的单次手术解剖成功率,但视力结果仍较差。需要进一步研究提高单次手术成功率的干预措施、ARN 的炎症并发症以及预防 ARN 相关 RD 的措施。